Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Bilal Zulfiqar & Vicky. M. Avery. (2022) Assay development in leishmaniasis drug discovery: a comprehensive review. Expert Opinion on Drug Discovery 17:2, pages 151-166.
Read now
Read now
Temmy Sunyoto, Marleen Boelaert & Filip Meheus. (2019) Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review. Expert Review of Anti-infective Therapy 17:1, pages 57-69.
Read now
Read now
José Angelo Lauletta Lindoso, Carlos Henrique Valente Moreira, Mirella Alves Cunha & Igor Thiago Queiroz. (2018) Visceral leishmaniasis and HIV coinfection: current perspectives. HIV/AIDS - Research and Palliative Care 10, pages 193-201.
Read now
Read now
Masoud Ghorbani & Ramin Farhoudi. (2018) Leishmaniasis in humans: drug or vaccine therapy?. Drug Design, Development and Therapy 12, pages 25-40.
Read now
Read now
Wanessa Trindade Clemente, Paulo Henrique Orlandi Mourão & Jose María Aguado. (2018) Current approaches to visceral leishmaniasis treatment in solid organ transplant recipients. Expert Review of Anti-infective Therapy 16:5, pages 391-397.
Read now
Read now
Natascia Bruni, Barbara Stella, Leonardo Giraudo, Carlo Della Pepa, Daniela Gastaldi & Franco Dosio. (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. International Journal of Nanomedicine 12, pages 5289-5311.
Read now
Read now
Muzamil Y Want, Mohammad Islammudin, Garima Chouhan, Hani A Ozbak, Hassan A Hemeg, Asoke P Chattopadhyay & Farhat Afrin. (2017) Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis. International Journal of Nanomedicine 12, pages 2189-2204.
Read now
Read now
José Angelo Lauletta Lindoso, Mirella Alves Cunha, Igor Thiago Queiroz & Carlos Henrique Valente Moreira. (2016) Leishmaniasis–HIV coinfection: current challenges. HIV/AIDS - Research and Palliative Care 8, pages 147-156.
Read now
Read now
Alice Machado-Silva, Pedro Pires Goulart Guimarães, Carlos Alberto Pereira Tavares & Rubén Dario Sinisterra. (2015) New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape. Expert Opinion on Therapeutic Patents 25:3, pages 247-260.
Read now
Read now
Articles from other publishers (109)
Mariza Gabriela Faleiro de Moura Lodi Cruz, Ana Maria Murta Santi, Eliane de Morais-Teixeira, Alisson Samuel Portes Caldeira, Ezequias Pessoa de Siqueira, Edward Oliveira, Tânia Maria de Almeida Alves & Silvane Maria Fonseca Murta. (2023)
Anti-
Leishmania
compounds can be screened using
Leishmania
spp. expressing red fluorescence (
tdTomato
)
. Antimicrobial Agents and Chemotherapy.
Crossref
Crossref
Lucas Bonatto de Souza Lima, Rafael Andrade Menolli & Thais Soprani Ayala. (2023) Immunomodulation of Macrophages May Benefit Cutaneous Leishmaniasis Outcome. Current Tropical Medicine Reports.
Crossref
Crossref
Bahareh Haji Ali, Milad Shirvaliloo, Sonia Fathi‐Karkan, Shekoufeh Mirinejad, Fulden Ulucan‐Karnak, Saman Sargazi, Sara Sargazi, Roghayeh Sheervalilou & Mohammed M. Rahman. (2023) Nanotechnology‐Based Strategies for Extended‐Release Delivery of Angiotensin Receptor Blockers (ARBs): A Comprehensive Review. Chemistry & Biodiversity 20:11.
Crossref
Crossref
Mujeeb Ur Rahman, Momin Khan, Sher Wali Khan, Rahat Ullah Khan, Aamir Sohail, Ali Zaman & Naveed Alam. (2023) Novel Schiff bases of Vanillin: potent inhibitors of macrophage harbored Leishmania tropica. Journal of Parasitic Diseases 47:3, pages 619-629.
Crossref
Crossref
Ganesh Yadagiri, Aakriti Singh, Kanika Arora & Shyam Lal Mudavath. (2023) Immunotherapy and immunochemotherapy in combating visceral leishmaniasis. Frontiers in Medicine 10.
Crossref
Crossref
Kübra Kelleci & Eda Gölebatmaz. (2022) In Vitro Determination of Antileshmanial Activities of Benzimidazolium Derivatives on L. major Promastigotes and Amastigotes. Acta Parasitologica 68:1, pages 51-55.
Crossref
Crossref
Tauane G. Soyer, Fernanda F. Ramos, Isabela A. G. Pereira, Daniela P. Lage, Raquel S. Bandeira, Marcelo M. de Jesus, Guilherme P. Costa, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Vívian T. Martins, Alexsandro S. Galdino, Miguel A. Chávez-Fumagalli, Daniel Menezes-Souza, Mariana C. Duarte, Bruno M. Roatt, Eduardo A. F. Coelho & Grasiele S. V. Tavares. (2023) Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis. Pathogens 12:2, pages 314.
Crossref
Crossref
Muhammad Adil, Pragya Tiwari, Mavara Iqbal, Shamsa Kanwal & Aisha Umar. 2023. Pharmacological Benefits of Natural Agents. Pharmacological Benefits of Natural Agents
225
249
.
Keerti, Narendra Kumar Yadav, Sumit Joshi, Sneha Ratnapriya, Amogh Anant Sahasrabuddhe & Anuradha Dube. (2023) Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis. Journal of Microbiology, Immunology and Infection 56:1, pages 163-171.
Crossref
Crossref
Edward T. Ryan, Julie R. Gutman & Rebecca J. Chancey. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1598
1617.e2
.
Prakash Kumar, Pawan Kumar, Nidhi Singh, Salil Khajuria, Rahul Patel, Vinod Kumar Rajana, Debabrata Mandal & Ravichandiran Velayutham. (2022) Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Tara E Ness, Rachel Martin-Blais & Jill E Weatherhead. (2022) How I Approach Leishmaniasis: Diagnosis and Treatment in the United States. Journal of the Pediatric Infectious Diseases Society 11:11, pages 525-532.
Crossref
Crossref
Kentaro Imaizumi, Thararat Phurahong, Suradej Siripattanapipong, Kiattawee Choowongkomon, Saovanee Leelayoova, Mathirut Mungthin, Teerasak E-kobon & Sasimanas Unajak. (2022) Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both Leishmania martiniquensis and Leishmania orientalis Parasites Using Immunoinformatic Approaches. Biology 11:10, pages 1460.
Crossref
Crossref
Edubiel A. Alpizar-Sosa, Nur Raihana Binti Ithnin, Wenbin Wei, Andrew W. Pountain, Stefan K. Weidt, Anne M. Donachie, Ryan Ritchie, Emily A. Dickie, Richard J. S. Burchmore, Paul W. Denny & Michael P. Barrett. (2022) Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response. PLOS Neglected Tropical Diseases 16:9, pages e0010779.
Crossref
Crossref
Gabriel Naylor-Leyland, Simon M. Collin, Francis Gatluak, Margriet den Boer, Fabiana Alves, Abdul Wasay Mullahzada & Koert Ritmeijer. (2022) The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018. PLOS Neglected Tropical Diseases 16:8, pages e0010696.
Crossref
Crossref
Nataly Paredes da Rocha, Eduardo José Barbosa, Gabriel Lima Barros de Araujo & Nádia Araci Bou-Chacra. (2022) Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, Venereology and Leprology 88, pages 437-442.
Crossref
Crossref
Julián Medina, Lissa Cruz-Saavedra, Luz Helena Patiño, Marina Muñoz & Juan David Ramírez. (2021) Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony. Parasites & Vectors 14:1.
Crossref
Crossref
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia & Vikramdeep Monga. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships. European Journal of Medicinal Chemistry 223, pages 113606.
Crossref
Crossref
Abeer M. El Sayed & Chukwuebuka Egbuna. 2021. Neglected Tropical Diseases and Phytochemicals in Drug Discovery. Neglected Tropical Diseases and Phytochemicals in Drug Discovery
75
134
.
Sriram Kannan, Yifat Harel, Esthy Levy, Avishay Dolitzky, Assaf E. Sagiv, Saurav Aryal, Laila Suleman, Jean-Paul Lellouche & Shulamit Michaeli. (2021) Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis. Journal of Controlled Release 335, pages 203-215.
Crossref
Crossref
Elvira Cynthia Alves Horácio, Jéssica Hickson, Silvane Maria Fonseca Murta, Jeronimo Conceição Ruiz & Laila Alves Nahum. (2021) Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Mahboobeh Jafari, Samira Sadat Abolmaali, Ali Mohammad Tamaddon, Kamiar Zomorodian & Bahador Shahriarirad (Sarkari). (2021) Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine 16:10, pages 857-877.
Crossref
Crossref
Gulab Fatima Rani, Olivier Preham, Helen Ashwin, Najmeeyah Brown, Ian S. Hitchcock & Paul M. Kaye. (2021) Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis. Blood Advances 5:6, pages 1627-1637.
Crossref
Crossref
Md. Rezaul Ekram, Mohammad Robed Amin, Mohammad Jahid Hasan, Md. Abdullah Saeed Khan, Rajib Nath, Pranab Kumar Mallik, Alex Lister & Monjur Rahman. (2021) Efficacy and safety of single-dose liposomal amphotericin B in patients with visceral leishmaniasis in Bangladesh: a real-life experience. Journal of Parasitic Diseases.
Crossref
Crossref
Tanja Barth-Jaeggi & Pascal Mäser. 2021. Neglected Tropical Diseases - Europe and Central Asia. Neglected Tropical Diseases - Europe and Central Asia
83
99
.
Birhanu Ayelign, Mohammedamin Jemal, Markos Negash, Meaza Genetu, Tadelo Wondmagegn, Ayalew Jejaw Zeleke, Ligabaw Worku, Abebe Genetu Bayih, Girma Shumie, Sinknesh Wolde Behaksra, Tiruwork Fenta, Demekech Damte, Arega Yeshanew & Endalamaw Gadisa. (2020) Validation of in-house liquid direct agglutination test antigen: the potential diagnostic test in visceral Leishimaniasis endemic areas of Northwest Ethiopia. BMC Microbiology 20:1.
Crossref
Crossref
Bruno Mendes Roatt, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Wendel Coura-Vital, Rodrigo Dian de Oliveira Aguiar-Soares & Alexandre Barbosa Reis. (2020) Recent advances and new strategies on leishmaniasis treatment. Applied Microbiology and Biotechnology 104:21, pages 8965-8977.
Crossref
Crossref
Sushobhan Mukhopadhyay, Dinesh S. Barak, R. Karthik, Sarvesh K. Verma, Rabi S. Bhatta, Neena Goyal & Sanjay Batra. (2020)
Antileishmanial assessment of isoxazole derivatives against
L. donovani
. RSC Medicinal Chemistry 11:9, pages 1053-1062.
Crossref
Crossref
Humera Ahmed, Charlotte R. Curtis, Sara Tur-Gracia, Toluwanimi O. Olatunji, Katharine C. Carter & Roderick A. M. Williams. (2020)
Drug combinations as effective anti-leishmanials against drug resistant
Leishmania mexicana
. RSC Medicinal Chemistry 11:8, pages 905-912.
Crossref
Crossref
Abdelhalim Babiker Mahmoud, Ombeline Danton, Marcel Kaiser, Sohee Han, Aitor Moreno, Shereen Abd Algaffar, Sami Khalid, Won Keun Oh, Matthias Hamburger & Pascal Mäser. (2020) Lignans, Amides, and Saponins from Haplophyllum tuberculatum and Their Antiprotozoal Activity. Molecules 25:12, pages 2825.
Crossref
Crossref
Salwa S. Sheikh, Amaar A. Amir, Baraa A. Amir & Abdulrazack A. Amir. 2020. Parasitology and Microbiology Research. Parasitology and Microbiology Research.
Juliana Kovalczuk de Oliveira, Tânia Ueda-Nakamura, Arlene Gonçalves Corrêa, Raquel Petrilli, Renata Fonseca Vianna Lopez, Celso Vataru Nakamura & Rachel Auzely-Velty. (2020) Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis. Materials Science and Engineering: C 110, pages 110720.
Crossref
Crossref
María Claudia Rodríguez GalvisJairo Enrique Pérez FrancoMirian Yolanda Casas Vargas & María Fernanda Ordoñez Rubiano. (2020) Effectiveness and Safety of Amphotericin B Deoxycholate, Amphotericin B Colloidal Dispersion, and Liposomal Amphotericin B as Third-Line Treatments for Cutaneous and Mucocutaneous Leishmaniasis: A Retrospective Study. The American Journal of Tropical Medicine and Hygiene 102:2, pages 274-279.
Crossref
Crossref
Xiaoxv Dong, Yawen Zeng, Yi Liu, Longtai You, Xingbin Yin, Jing Fu & Jian Ni. (2019) Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics. Phytotherapy Research 34:2, pages 270-281.
Crossref
Crossref
Marco Vinicius Chaud, Venâncio Alves Amaral, Fernando Batain, Kessi Marie Moura Crescencio, Carolina Alves dos Santos, Márcia Araújo Rebelo & Victória Soares Soeiro. 2020. Nanotechnology in Skin, Soft Tissue, and Bone Infections. Nanotechnology in Skin, Soft Tissue, and Bone Infections
183
204
.
Rosa M. Reguera, Ehab K. Elmahallawy, Carlos García-Estrada, Rubén Carbajo-Andrés & Rafael Balaña-Fouce. (2019) DNA Topoisomerases of Leishmania Parasites; Druggable Targets for Drug Discovery. Current Medicinal Chemistry 26:32, pages 5900-5923.
Crossref
Crossref
Maryam Hakimi Parizi, Abbas Pardakhty, Iraj sharifi, Saeedeh Farajzadeh, Mohammad Hossein Daie Parizi, Hamid Sharifi, Ali Reza Keyhani, Mahshid Mostafavi, Mehdi Bamorovat & Daryoush Ghaffari. (2019) Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica. Journal of Parasitic Diseases 43:3, pages 406-415.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Malcolm S Duthie, Yasuyuki Goto, Prakash Ghosh & Dinesh Mondal. (2019) Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani. Pathogens and Disease 77:6.
Crossref
Crossref
Pulin Kumar Gupta, Subodh Kumar Mahto, Abhishek Mittal, Mahinder Pal S. Chawla, Manju Kaushal & Arvind Kumar. (2019) Disseminated Leishmaniasis With Immune Reconstitution Inflammatory Syndrome–associated Pneumocystis Pneumonia in a Human Immunodeficiency Virus–infected Patient With First-line Antiretroviral Therapy Failure. Infectious Diseases in Clinical Practice 27:3, pages e8-e10.
Crossref
Crossref
Jie Tang, Santhanakrishnan Srinivasan, Wenmin Yuan, Ran Ming, Yayuan Liu, Zhipeng Dai, Charles O. Noble, Mark E. Hayes, Nan Zheng, Wenlei Jiang, Francis C. Szoka & Anna Schwendeman. (2019) Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome. European Journal of Pharmaceutics and Biopharmaceutics 134, pages 107-116.
Crossref
Crossref
Ligia N.M. Ribeiro, Ana C.S. Alcantara, Michelle Franz-Montan, Veronica M. Couto, Silvia V.G. Nista & Eneida de Paula. 2019. Biomedical Applications of Nanoparticles. Biomedical Applications of Nanoparticles
341
374
.
Ali Medbouhi, Aura Tintaru, Claire Beaufay, Jean-Valère Naubron, Nassim Djabou, Jean Costa, Joëlle Quetin-Leclercq & Alain Muselli. (2018) Structural Elucidation and Cytotoxicity of a New 17-Membered Ring Lactone from Algerian Eryngium campestre. Molecules 23:12, pages 3250.
Crossref
Crossref
Gert-Jan Wijnant, Katrien Van Bocxlaer, Amanda Fortes Francisco, Vanessa Yardley, Andy Harris, Mo Alavijeh, Sudaxshina Murdan & Simon L. Croft. (2018) Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Sakib Burza, Simon L Croft & Marleen Boelaert. (2018) Leishmaniasis. The Lancet 392:10151, pages 951-970.
Crossref
Crossref
Charles Abongomera, Ermias Diro, Alan de Lima Pereira, Jozefien Buyze, Kolja Stille, Fareed Ahmed, Johan van Griensven & Koert Ritmeijer. (2018) The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study. PLOS Neglected Tropical Diseases 12:5, pages e0006527.
Crossref
Crossref
Hannah Akuffo, Carlos Costa, Johan van Griensven, Sakib Burza, Javier Moreno & Mercè Herrero. (2018) New insights into leishmaniasis in the immunosuppressed. PLOS Neglected Tropical Diseases 12:5, pages e0006375.
Crossref
Crossref
SILVIA R. B. ULIANA, CRISTIANA T. TRINCONI & ADRIANO C. COELHO. (2017) Chemotherapy of leishmaniasis: present challenges. Parasitology 145:4, pages 464-480.
Crossref
Crossref
Y. TASLIMI, F. ZAHEDIFARD & S. RAFATI. (2016) Leishmaniasis and various immunotherapeutic approaches. Parasitology 145:4, pages 497-507.
Crossref
Crossref
S HENDRICKX, PJ GUERIN, G CALJON, SL CROFT & L MAES. (2016) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology 145:4, pages 453-463.
Crossref
Crossref
Raghavan Srinivasan, Tanwir Ahmad, Vidya Raghavan, Manisha Kaushik & Ramakant Pathak. (2018) Positive Influence of Behavior Change Communication on Knowledge, Attitudes, and Practices for Visceral Leishmaniasis/Kala-azar in India. Global Health: Science and Practice 6:1, pages 192-209.
Crossref
Crossref
Laís Anversa, Monique Gomes Salles Tiburcio, Virgínia Bodelão Richini-Pereira & Luis Eduardo Ramirez. (2018) Human leishmaniasis in Brazil: A general review. Revista da Associação Médica Brasileira 64:3, pages 281-289.
Crossref
Crossref
Seyedeh Sedigheh Hamzavi, Anahita Sanaei Dashti, Mohammad Rahim Kadivar, Gholamreza Pouladfar & Bahman Pourabbas. (2018) Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl. Pediatric Infectious Disease Journal 37:3, pages 275-277.
Crossref
Crossref
Débora V.C. Mendonça, Vívian T. Martins, Daniela P. Lage, Daniel S. Dias, Patrícia A.F. Ribeiro, Ana Maria R.S. Carvalho, Anna Letícia T. Dias, Carolina K. Miyazaki, Daniel Menezes-Souza, Bruno M. Roatt, Carlos A.P. Tavares, José Mário Barichello, Mariana C. Duarte & Eduardo A.F. Coelho. (2018) Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. Experimental Parasitology 186, pages 24-35.
Crossref
Crossref
Daan Vorselen, Margherita Marchetti, Carmen López-Iglesias, Peter J. Peters, Wouter H. Roos & Gijs J. L. Wuite. (2018) Multilamellar nanovesicles show distinct mechanical properties depending on their degree of lamellarity. Nanoscale 10:11, pages 5318-5324.
Crossref
Crossref
Edward T. Ryan. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1567
1587.e2
.
João Henrique G. Lago, Kaidu H. Barrosa, Samanta Etel T. Borborema & André G. Tempone. 2018. Natural Antimicrobial Agents. Natural Antimicrobial Agents
195
214
.
Suzette S. Kämink, Simon M. Collin, Tim Harrison, Francis Gatluak, Abdul Wasay Mullahzada & Koert Ritmeijer. (2017) A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan. PLOS Neglected Tropical Diseases 11:10, pages e0005921.
Crossref
Crossref
Andrew A. Voak, Andy Harris, Zeeshan Qaiser, Simon L. Croft & Karin Seifert. (2017) Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
Sanjay Varikuti, Steve Oghumu, Noushin Saljoughian, Marissa S. Pioso, Bren E Sedmak, Ali Khamesipour & Abhay R. Satoskar. (2017) Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana. Acta Tropica 173, pages 102-108.
Crossref
Crossref
. 2017. Carrier‒Mediated Dermal Delivery. Carrier‒Mediated Dermal Delivery
385
430
.
Laís Anversa, Monique Gomes Salles Tiburcio, Lara Rocha Batista, Marília Beatriz Cuba, Gabriel Antonio Nogueira Nascentes, Tábata Yamasaki Martins, Virgínia Bodelão Richini Pereira, Luciana da Silva Ruiz, Valdo José Dias da Silva & Luis Eduardo Ramirez. (2017) Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis. International Journal of Antimicrobial Agents 50:2, pages 159-165.
Crossref
Crossref
Gustavo Adolfo Sierra Romero, Dorcas Lamounier Costa, Carlos Henrique Nery Costa, Roque Pacheco de Almeida, Enaldo Viera de Melo, Sílvio Fernando Guimarães de Carvalho, Ana Rabello, Andréa Lucchesi de Carvalho, Anastácio de Queiroz Sousa, Robério Dias Leite, Simone Soares Lima, Thais Alves Amaral, Fabiana Piovesan Alves & Joelle Rode. (2017) Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial. PLOS Neglected Tropical Diseases 11:6, pages e0005706.
Crossref
Crossref
Roy Mwenechanya, Julie Kovářová, Nicholas J. Dickens, Manikhandan Mudaliar, Pawel Herzyk, Isabel M. Vincent, Stefan K. Weidt, Karl E. Burgess, Richard J. S. Burchmore, Andrew W. Pountain, Terry K. Smith, Darren J. Creek, Dong-Hyun Kim, Galina I. Lepesheva & Michael P. Barrett. (2017) Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana. PLOS Neglected Tropical Diseases 11:6, pages e0005649.
Crossref
Crossref
German A. Islan, Marcela Durán, Maximiliano L. Cacicedo, Gerson Nakazato, Renata K.T. Kobayashi, Diego S.T. Martinez, Guillermo R. Castro & Nelson Durán. (2017) Nanopharmaceuticals as a solution to neglected diseases: Is it possible?. Acta Tropica 170, pages 16-42.
Crossref
Crossref
Morgana V. de Araújo, Cibelle Cabral David, José Clementino Neto, Luiz A.P.L. de Oliveira, Karoline Cristina Jatobá da Silva, Jefferson Miguel dos Santos, João Kayke S. da Silva, Victoria B.C. de A Brandão, Tania M.S. Silva, Celso A. Camara & Magna S. Alexandre-Moreira. (2017) Evaluation on the leishmanicidal activity of 2-N,N′-dialkylamino-1,4-naphthoquinone derivatives. Experimental Parasitology 176, pages 46-51.
Crossref
Crossref
Maximiliano Cacicedo, Germán Islan, Pablo Gurman & Guillermo Castro. 2017. Drug Delivery. Drug Delivery
349
372
.
Samira Azzouz & Philippe Lawton. (2017) In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes. Acta Parasitologica 62:3.
Crossref
Crossref
Fatemeh Maleki, Mitra Zarebavani, Mehdi Mohebali, Mohammad Saaid Dayer, Fateme Hajialiani & Fatemeh Tabatabaie. (2017) In?vitro and in?vivo susceptibility of Leishmania major to some medicinal plants. Asian Pacific Journal of Tropical Biomedicine 7:1, pages 37-42.
Crossref
Crossref
Robert N. Davidson. 2017. Infectious Diseases. Infectious Diseases
1059
1064.e1
.
R. Shivahare, W. Ali, U. S. Singh, S. M. Natu, S. Khattri, S. K. Puri & S. Gupta. (2016)
Immunoprotective effect of lentinan in combination with miltefosine on
Leishmania-
infected J-774A.1 macrophages
. Parasite Immunology 38:10, pages 618-627.
Crossref
Crossref
Sanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, Brajendra Tiwari, Dadi A. Srinivasarao, Anuradha Dube, Neena Goyal & Amit Misra. (2016) Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. International Journal for Parasitology: Drugs and Drug Resistance 6:2, pages 125-132.
Crossref
Crossref
Sostenes Mistro, Marlon Rodrigues, Lorena Rosa, Marianne Camargo & Roberto Badaró. (2016) Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil. Tropical Medicine & International Health 21:6, pages 692-693.
Crossref
Crossref
Samanta Etel Treiger Borborema, João Alberto Osso Junior, Heitor Franco de Andrade Junior & Nanci do Nascimento. (2016) Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity. Revista da Sociedade Brasileira de Medicina Tropical 49:2, pages 196-203.
Crossref
Crossref
Johan van Griensven, Endalamaw Gadisa, Abraham Aseffa, Asrat Hailu, Abate Mulugeta Beshah & Ermias Diro. (2016) Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review. PLOS Neglected Tropical Diseases 10:3, pages e0004495.
Crossref
Crossref
Jill P Adler-Moore, Jean-Pierre Gangneux & Peter G Pappas. (2016) Comparison between liposomal formulations of amphotericin B. Medical Mycology 54:3, pages 223-231.
Crossref
Crossref
Elham Nikzad, Fatemeh Abdollahi & Seyed Mohammadreza Hashemian. (2016) Liposomal Amphotericin B Usefulness in Critical Care Unit: A Review Study. Archives of Critical Care Medicine 2:1.
Crossref
Crossref
Aditya Satpati, Sukhen Das, Rudra P. Goswami, Rama P. Goswami & Mehebubar Rahman. (2016) Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome?). The American Journal of Tropical Medicine and Hygiene 94:1, pages 93-98.
Crossref
Crossref
Víctor Gutiérrez, Amedea B. Seabra, Rosa M. Reguera, Jayant Khandare & Marcelo Calderón. (2016) New approaches from nanomedicine for treating leishmaniasis. Chemical Society Reviews 45:1, pages 152-168.
Crossref
Crossref
V. Ramesh & Prashant Verma. 2016. Kala Azar in South Asia. Kala Azar in South Asia
67
77
.
Marc Z. Handler, Parimal A. Patel, Rajendra Kapila, Yasin Al-Qubati & Robert A. Schwartz. (2015) Cutaneous and mucocutaneous leishmaniasis. Journal of the American Academy of Dermatology 73:6, pages 911-926.
Crossref
Crossref
Karin Seifert, Christiane Juhls, Francisco J. Salguero & Simon L. Croft. (2015) Sequential Chemoimmunotherapy of Experimental Visceral Leishmaniasis Using a Single Low Dose of Liposomal Amphotericin B and a Novel DNA Vaccine Candidate. Antimicrobial Agents and Chemotherapy 59:9, pages 5819-5823.
Crossref
Crossref
Priyadharsini Nagarajan & Brett S. Sloan. (2015) Isolated Cutaneous Leishmaniasis by Leishmania donovani in a Soldier Returning From Afghanistan. The American Journal of Dermatopathology 37:7, pages 591-592.
Crossref
Crossref
Niyati H. Vakil, Noriko Fujinami & Punit J. Shah. (2015) Pharmacotherapy for Leishmaniasis in the United States: Focus on Miltefosine. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:5, pages 536-545.
Crossref
Crossref
Emiliano Lucero, Simon M. Collin, Sujit Gomes, Fatima Akter, Asaduzzam Asad, Asish Kumar Das & Koert Ritmeijer. (2015) Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh. PLOS Neglected Tropical Diseases 9:4, pages e0003699.
Crossref
Crossref
Abdolhossein Dalimi, Mahdi Delavari, Fatemeh Ghaffarifar & Javid Sadraei. (2015) In?vitro and in?vivo antileishmanial effects of aloe-emodin on Leishmania major. Journal of Traditional and Complementary Medicine 5:2, pages 96-99.
Crossref
Crossref
Pratik Adhikari, Wakako Eklund & D. P. O'Neal. Non-invasive in vivo monitoring of circulating amphotericin b using multi-wavelength photoplethysmography. Non-invasive in vivo monitoring of circulating amphotericin b using multi-wavelength photoplethysmography.
MD Mignogna, A Celentano, S Leuci, M Cascone, D Adamo, E Ruoppo & G Favia. (2014) Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature. Oral Diseases 21:1.
Crossref
Crossref
Daan J.A. Crommelin, Josbert M. Metselaar & Gert Storm. 2015. Non-Biological Complex Drugs. Non-Biological Complex Drugs
77
106
.
Shyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, Tara Kant Jha, Vidya Nand Ravi Das, Neena Verma, Chandra Shekhar Lal, Deepak Verma, Shahnawaz Alam & Pradeep Das. (2014) Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study. PLoS Neglected Tropical Diseases 8:9, pages e3169.
Crossref
Crossref
Sakib Burza, Raman Mahajan, Prabhat K. Sinha, Johan van Griensven, Krishna Pandey, Mar?a Angeles Lima, Marta Gonzalez Sanz, Temmy Sunyoto, Sunil Kumar, Gaurab Mitra, Ranjeet Kumar, Neena Verma & Pradeep Das. (2014) Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome). PLoS Neglected Tropical Diseases 8:8, pages e3053.
Crossref
Crossref
Shalom Patole, Sakib Burza & George M. Varghese. (2014) Multiple relapses of visceral leishmaniasis in a patient with HIV in India: A treatment challenge. International Journal of Infectious Diseases 25, pages 204-206.
Crossref
Crossref
CD Shaw & KC Carter. (2014)
Drug delivery: lessons to be learnt from
Leishmania
studies
. Nanomedicine 9:10, pages 1531-1544.
Crossref
Crossref
Sebastian F.N. Bode, Christian Bogdan, Karin Beutel, Wolfgang Behnisch, Jeanette Greiner, Stephan Henning, Norbert Jorch, Martin Jankofsky, Marcus Jakob, Irene Schmid, Norbert Veelken, Thomas Vraetz, Gritta Janka, Stephan Ehl & Kai Lehmberg. (2014) Hemophagocytic Lymphohistiocytosis in Imported Pediatric Visceral Leishmaniasis in a Nonendemic Area. The Journal of Pediatrics 165:1, pages 147-153.e1.
Crossref
Crossref
Ermias Diro, Lutgarde Lynen, Rezika Mohammed, Marleen Boelaert, Asrat Hailu & Johan van Griensven. (2014) High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia. PLoS Neglected Tropical Diseases 8:5, pages e2875.
Crossref
Crossref
Fábio A.E. Torres, Thais G. Passalacqua, Angela M.A. Velásquez, Rodrigo A. de Souza, Pio Colepicolo & Márcia A.S. Graminha. (2014) New drugs with antiprotozoal activity from marine algae: a review. Revista Brasileira de Farmacognosia 24:3, pages 265-276.
Crossref
Crossref
Kelly L. Johnston, Louise Ford & Mark J. Taylor. (2014) Overcoming the Challenges of Drug Discovery for Neglected Tropical Diseases: The A·WOL Experience. SLAS Discovery 19:3, pages 335-343.
Crossref
Crossref
Niven A. Salih, Johan van Griensven, Fran?ois Chappuis, Annick Antierens, Ann Mumina, Omar Hammam, Philippa Boulle, Emilie Alirol, Mubarak Alnour, Mousab S. Elhag, Marcel Manzi, Walter Kizito & Rony Zachariah. (2014) Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?. Tropical Medicine & International Health 19:2, pages 146-152.
Crossref
Crossref
Shweta, Surabhi Bhatnagar, Ashok Kumar Gupta, Krishna Murti & Krishna Pandey. (2014) Co?infection of visceral leishmaniasis and pulmonary tuberculosis: a case study. Asian Pacific Journal of Tropical Disease 4:1, pages 57-60.
Crossref
Crossref
Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan, Marta González Sanz, María Angeles Lima, Gaurab Mitra, Neena Verma & Pradeep Das. (2014) Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India. PLoS Neglected Tropical Diseases 8:1, pages e2611.
Crossref
Crossref
Sakib Burza, Prabhat K. Sinha, Raman Mahajan, Mar?a Angeles Lima, Gaurab Mitra, Neena Verma, Manica Balasegarem & Pradeep Das. (2014) Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India. PLoS Neglected Tropical Diseases 8:1, pages e2603.
Crossref
Crossref
Sakib Burza, Prabhat K. Sinha, Raman Mahajan, María Angeles Lima, Gaurab Mitra, Neena Verma, Manica Balsegaram & Pradeep Das. (2014) Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. PLoS Neglected Tropical Diseases 8:1, pages e2536.
Crossref
Crossref
Eva-Maria Maintz, Mahbub Hassan, M. Mamun Huda, Debashis Ghosh, Md. Shakhawat Hossain, Abdul Alim, Axel Kroeger, Byron Arana & Dinesh Mondal. (2014) Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff. Journal of Tropical Medicine 2014, pages 1-7.
Crossref
Crossref
Shyamapada Mandal & Manisha Mandal. 2014. Liver Immunology. Liver Immunology
145
158
.
R. Bajoria, S. Sooranna & R. Chatterjee. (2013) Effect of lipid composition of cationic SUV liposomes on materno-fetal transfer of warfarin across the perfused human term placenta. Placenta 34:12, pages 1216-1222.
Crossref
Crossref
T.T.H. Pham, P.M. Loiseau & G. Barratt. (2013) Strategies for the design of orally bioavailable antileishmanial treatments. International Journal of Pharmaceutics 454:1, pages 539-552.
Crossref
Crossref
Gláucia F. Cota, Marcos R. de Sousa, Tatiani Oliveira Fereguetti & Ana Rabello. (2013) Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison. PLoS Neglected Tropical Diseases 7:5, pages e2195.
Crossref
Crossref
Ryan D. Boehm, Philip R. Miller, Wiley A. Schell, John R. Perfect & Roger J. Narayan. (2013) Inkjet Printing of Amphotericin B onto Biodegradable Microneedles Using Piezoelectric Inkjet Printing. JOM 65:4, pages 525-533.
Crossref
Crossref
Edson Carvalho de Melo & Carlos Magno Castelo Branco Fortaleza. (2013) Challenges in the Therapy of Visceral Leishmaniasis in Brazil: A Public Health Perspective. Journal of Tropical Medicine 2013, pages 1-5.
Crossref
Crossref